fanta.bio Sample: CNhs11877
22446 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| CTNNB1 SRX13991431 | MCF 10A Breast | 494 / 18305 (2.7%) | 204 / 183050 (0.1%) | −324.0 | −324.0 | 24.22 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1895 / 18305 (10.4%) | 785 / 183050 (0.4%) | −324.0 | −324.0 | 24.14 |
| SCML2 SRX644728 | 293 Kidney | 1655 / 18305 (9.0%) | 733 / 183050 (0.4%) | −324.0 | −324.0 | 22.58 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2589 / 18305 (14.1%) | 1187 / 183050 (0.6%) | −324.0 | −324.0 | 21.81 |
| HIF1A SRX11007095 | HK-2 Kidney | 2240 / 18305 (12.2%) | 1029 / 183050 (0.6%) | −324.0 | −324.0 | 21.77 |
| FOXP1 SRX736067 | LNCAP Prostate | 2298 / 18305 (12.6%) | 1056 / 183050 (0.6%) | −324.0 | −324.0 | 21.76 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2525 / 18305 (13.8%) | 1170 / 183050 (0.6%) | −324.0 | −324.0 | 21.58 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1051 / 18305 (5.7%) | 525 / 183050 (0.3%) | −324.0 | −324.0 | 20.02 |
| HIF1A SRX20663235 | HK-2 Kidney | 531 / 18305 (2.9%) | 290 / 183050 (0.2%) | −324.0 | −324.0 | 18.31 |
| MYH11 SRX265221 | ME-1 Blood | 1013 / 18305 (5.5%) | 594 / 183050 (0.3%) | −324.0 | −324.0 | 17.05 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1518 / 18305 (8.3%) | 916 / 183050 (0.5%) | −324.0 | −324.0 | 16.57 |
| MED1 SRX9419945 | BT-474 Breast | 3473 / 18305 (19.0%) | 3160 / 183050 (1.7%) | −324.0 | −324.0 | 10.99 |
| MED1 SRX9419944 | BT-474 Breast | 3361 / 18305 (18.4%) | 3105 / 183050 (1.7%) | −324.0 | −324.0 | 10.82 |
| MED1 SRX9419946 | BT-474 Breast | 3540 / 18305 (19.3%) | 3303 / 183050 (1.8%) | −324.0 | −324.0 | 10.72 |
| BRD4 SRX9419936 | BT-474 Breast | 3501 / 18305 (19.1%) | 3298 / 183050 (1.8%) | −324.0 | −324.0 | 10.62 |
| MED1 SRX9419947 | BT-474 Breast | 3409 / 18305 (18.6%) | 3228 / 183050 (1.8%) | −324.0 | −324.0 | 10.56 |
| BRD4 SRX9419937 | BT-474 Breast | 3343 / 18305 (18.3%) | 3193 / 183050 (1.7%) | −324.0 | −324.0 | 10.47 |
| BRD4 SRX9419935 | BT-474 Breast | 3333 / 18305 (18.2%) | 3200 / 183050 (1.7%) | −324.0 | −324.0 | 10.42 |
| BRD4 SRX9419938 | BT-474 Breast | 3449 / 18305 (18.8%) | 3312 / 183050 (1.8%) | −324.0 | −324.0 | 10.41 |
| EZH2 SRX2146136 | LNCAP Prostate | 8148 / 18305 (44.5%) | 8733 / 183050 (4.8%) | −324.0 | −324.0 | 9.33 |
| BRD4 SRX736201 | 90-8TL Neural | 5794 / 18305 (31.7%) | 7427 / 183050 (4.1%) | −324.0 | −324.0 | 7.80 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2023 / 18305 (11.1%) | 2920 / 183050 (1.6%) | −324.0 | −324.0 | 6.93 |
| KAT7 SRX101303 | RKO Digestive tract | 1727 / 18305 (9.4%) | 5346 / 183050 (2.9%) | −324.0 | −324.0 | 3.23 |
| PBX4 SRX2731658 | PC-3 Prostate | 962 / 18305 (5.3%) | 28843 / 183050 (15.8%) | −324.0 | −324.0 | 0.33 |
| FOS SRX150478 | MCF 10A Breast | 602 / 18305 (3.3%) | 22028 / 183050 (12.0%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757325 | H2052 Lung | 572 / 18305 (3.1%) | 22342 / 183050 (12.2%) | −324.0 | −324.0 | 0.26 |
| FOS SRX150477 | MCF 10A Breast | 538 / 18305 (2.9%) | 21502 / 183050 (11.7%) | −324.0 | −324.0 | 0.25 |
| YAP1 SRX757326 | H2052 Lung | 461 / 18305 (2.5%) | 20006 / 183050 (10.9%) | −324.0 | −324.0 | 0.23 |
| FOS SRX4192880 | MCF 10A Breast | 422 / 18305 (2.3%) | 17513 / 183050 (9.6%) | −318.0 | −314.9 | 0.24 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1440 / 18305 (7.9%) | 3998 / 183050 (2.2%) | −313.9 | −310.9 | 3.60 |
| BRD1 SRX286203 | RKO Digestive tract | 1500 / 18305 (8.2%) | 4323 / 183050 (2.4%) | −312.9 | −309.8 | 3.47 |
| TP53 SRX19538279 | Osteoblasts Bone | 506 / 18305 (2.8%) | 309 / 183050 (0.2%) | −308.8 | −305.8 | 16.38 |
| BRPF3 SRX796084 | RKO Digestive tract | 1867 / 18305 (10.2%) | 6480 / 183050 (3.5%) | −304.4 | −301.4 | 2.88 |
| Epitope tags SRX10549776 | K-562 Blood | 1679 / 18305 (9.2%) | 5529 / 183050 (3.0%) | −294.4 | −291.4 | 3.04 |
| SS18 SRX3468047 | Fibroblasts Others | 735 / 18305 (4.0%) | 21963 / 183050 (12.0%) | −292.3 | −289.3 | 0.33 |
| FOS SRX150517 | MCF 10A Breast | 464 / 18305 (2.5%) | 17465 / 183050 (9.5%) | −291.2 | −288.2 | 0.27 |
| AR SRX1067071 | LHSAR Prostate | 556 / 18305 (3.0%) | 18956 / 183050 (10.4%) | −288.8 | −285.9 | 0.29 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 696 / 18305 (3.8%) | 21215 / 183050 (11.6%) | −288.3 | −285.3 | 0.33 |
| JUNB SRX8488073 | SUM 229PE Breast | 513 / 18305 (2.8%) | 18210 / 183050 (9.9%) | −288.1 | −285.2 | 0.28 |
| MEAF6 DRX234811 | 293 Kidney | 2054 / 18305 (11.2%) | 7878 / 183050 (4.3%) | −286.9 | −283.9 | 2.61 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1040 / 18305 (5.7%) | 26337 / 183050 (14.4%) | −285.3 | −282.4 | 0.39 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1027 / 18305 (5.6%) | 26122 / 183050 (14.3%) | −284.7 | −281.8 | 0.39 |
| MEAF6 DRX300417 | 293 Kidney | 1897 / 18305 (10.4%) | 6960 / 183050 (3.8%) | −283.9 | −281.0 | 2.73 |
| TP53 SRX19538274 | U2OS Bone | 421 / 18305 (2.3%) | 193 / 183050 (0.1%) | −283.6 | −280.7 | 21.81 |
| JUN SRX17561461 | LPS141 Adipocyte | 383 / 18305 (2.1%) | 15683 / 183050 (8.6%) | −279.6 | −276.7 | 0.24 |
| BRPF3 SRX796086 | RKO Digestive tract | 1744 / 18305 (9.5%) | 6120 / 183050 (3.3%) | −278.7 | −275.9 | 2.85 |
| AGO2 SRX4708039 | Hep G2 Liver | 2067 / 18305 (11.3%) | 8093 / 183050 (4.4%) | −278.6 | −275.8 | 2.55 |
| JUNB SRX8488088 | SUM 229PE Breast | 559 / 18305 (3.1%) | 18672 / 183050 (10.2%) | −278.2 | −275.4 | 0.30 |
| Epitope tags DRX443510 | 293 Kidney | 1791 / 18305 (9.8%) | 6406 / 183050 (3.5%) | −278.1 | −275.3 | 2.80 |
| ING5 SRX286202 | RKO Digestive tract | 1614 / 18305 (8.8%) | 5441 / 183050 (3.0%) | −272.9 | −270.1 | 2.97 |
| FOS SRX150476 | MCF 10A Breast | 501 / 18305 (2.7%) | 17504 / 183050 (9.6%) | −271.9 | −269.1 | 0.29 |
| TP53 SRX19538276 | U2OS Bone | 414 / 18305 (2.3%) | 212 / 183050 (0.1%) | −269.0 | −266.2 | 19.53 |
| SMARCA4 SRX5212366 | Mel270 Others | 360 / 18305 (2.0%) | 14947 / 183050 (8.2%) | −268.8 | −266.0 | 0.24 |
| TP53 SRX19538268 | U2OS Bone | 408 / 18305 (2.2%) | 201 / 183050 (0.1%) | −268.5 | −265.8 | 20.30 |
| AR SRX10820653 | LNCAP Prostate | 403 / 18305 (2.2%) | 197 / 183050 (0.1%) | −265.9 | −263.1 | 20.46 |
| AR SRX1067070 | LHSAR Prostate | 771 / 18305 (4.2%) | 21606 / 183050 (11.8%) | −264.8 | −262.0 | 0.36 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 642 / 18305 (3.5%) | 19586 / 183050 (10.7%) | −264.7 | −261.9 | 0.33 |
| BRPF3 SRX796085 | RKO Digestive tract | 1293 / 18305 (7.1%) | 3788 / 183050 (2.1%) | −262.8 | −260.1 | 3.41 |
| JUN SRX6582171 | GM07492 Others | 579 / 18305 (3.2%) | 18464 / 183050 (10.1%) | −261.3 | −258.6 | 0.31 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 256 / 18305 (1.4%) | 12739 / 183050 (7.0%) | −260.1 | −257.4 | 0.20 |
| MAU2 SRX15710550 | Fibroblasts Others | 476 / 18305 (2.6%) | 16713 / 183050 (9.1%) | −260.0 | −257.3 | 0.28 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 678 / 18305 (3.7%) | 1011 / 183050 (0.6%) | −259.1 | −256.4 | 6.71 |
| FOS SRX4192879 | MCF 10A Breast | 312 / 18305 (1.7%) | 13750 / 183050 (7.5%) | −258.3 | −255.5 | 0.23 |
| ESR1 SRX4367193 | MCF-7 Breast | 1084 / 18305 (5.9%) | 25887 / 183050 (14.1%) | −255.0 | −252.3 | 0.42 |
| SMARCA4 SRX5212362 | Mel270 Others | 519 / 18305 (2.8%) | 17217 / 183050 (9.4%) | −253.1 | −250.4 | 0.30 |
| TP53 SRX19538267 | U2OS Bone | 375 / 18305 (2.0%) | 171 / 183050 (0.1%) | −253.0 | −250.3 | 21.93 |
| SMARCA4 SRX5212357 | Mel270 Others | 419 / 18305 (2.3%) | 15496 / 183050 (8.5%) | −252.4 | −249.7 | 0.27 |
| SMARCA4 SRX5212371 | Mel270 Others | 411 / 18305 (2.2%) | 15324 / 183050 (8.4%) | −251.3 | −248.7 | 0.27 |
| JUNB SRX8488074 | SUM 229PE Breast | 376 / 18305 (2.1%) | 14703 / 183050 (8.0%) | −251.2 | −248.5 | 0.26 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1053 / 18305 (5.8%) | 25294 / 183050 (13.8%) | −250.8 | −248.2 | 0.42 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1218 / 18305 (6.7%) | 27619 / 183050 (15.1%) | −250.8 | −248.1 | 0.44 |
| ESR1 SRX176861 | MCF-7 Breast | 519 / 18305 (2.8%) | 17126 / 183050 (9.4%) | −250.3 | −247.7 | 0.30 |
| SMARCA2 SRX8119677 | MeT-5A Others | 492 / 18305 (2.7%) | 16670 / 183050 (9.1%) | −250.2 | −247.5 | 0.30 |
| ESR1 SRX371478 | MCF-7 Breast | 395 / 18305 (2.2%) | 15005 / 183050 (8.2%) | −250.1 | −247.4 | 0.26 |
| ESR1 SRX176860 | MCF-7 Breast | 522 / 18305 (2.9%) | 17142 / 183050 (9.4%) | −249.2 | −246.6 | 0.30 |
| EP300 SRX2671813 | Fibroblasts Others | 208 / 18305 (1.1%) | 11380 / 183050 (6.2%) | −245.9 | −243.2 | 0.18 |
| ESR1 SRX20282961 | MCF-7 Breast | 392 / 18305 (2.1%) | 14815 / 183050 (8.1%) | −245.5 | −242.9 | 0.26 |
| JUN SRX6582172 | Fibroblasts Others | 393 / 18305 (2.1%) | 14705 / 183050 (8.0%) | −241.4 | −238.8 | 0.27 |
| NR3C1 SRX2609664 | HASM2 Lung | 426 / 18305 (2.3%) | 15243 / 183050 (8.3%) | −240.4 | −237.7 | 0.28 |
| ESR1 SRX20282960 | MCF-7 Breast | 353 / 18305 (1.9%) | 13960 / 183050 (7.6%) | −240.2 | −237.6 | 0.25 |
| ESR1 SRX7624157 | MCF-7 Breast | 888 / 18305 (4.9%) | 22474 / 183050 (12.3%) | −239.2 | −236.6 | 0.40 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 756 / 18305 (4.1%) | 20499 / 183050 (11.2%) | −239.0 | −236.4 | 0.37 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 249 / 18305 (1.4%) | 11997 / 183050 (6.6%) | −239.0 | −236.4 | 0.21 |
| TP53 SRX19538273 | U2OS Bone | 364 / 18305 (2.0%) | 181 / 183050 (0.1%) | −238.8 | −236.2 | 20.11 |
| TP53 SRX19538281 | Osteoblasts Bone | 428 / 18305 (2.3%) | 330 / 183050 (0.2%) | −237.1 | −234.6 | 12.97 |
| TP53 SRX19538280 | Osteoblasts Bone | 389 / 18305 (2.1%) | 241 / 183050 (0.1%) | −236.0 | −233.4 | 16.14 |
| TP53 SRX19538275 | U2OS Bone | 370 / 18305 (2.0%) | 201 / 183050 (0.1%) | −235.5 | −233.0 | 18.41 |
| JUNB SRX10119386 | MCF 10A Breast | 250 / 18305 (1.4%) | 11909 / 183050 (6.5%) | −235.3 | −232.7 | 0.21 |
| ESR1 SRX371479 | MCF-7 Breast | 281 / 18305 (1.5%) | 12473 / 183050 (6.8%) | −234.4 | −231.9 | 0.23 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1365 / 18305 (7.5%) | 28953 / 183050 (15.8%) | −233.0 | −230.4 | 0.47 |
| JUNB SRX8488089 | SUM 229PE Breast | 288 / 18305 (1.6%) | 12556 / 183050 (6.9%) | −232.8 | −230.2 | 0.23 |
| JUN SRX4192884 | MCF 10A Breast | 228 / 18305 (1.2%) | 11396 / 183050 (6.2%) | −232.5 | −229.9 | 0.20 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 979 / 18305 (5.3%) | 23541 / 183050 (12.9%) | −232.1 | −229.6 | 0.42 |
| GATA3 SRX190194 | SK-N-SH Neural | 809 / 18305 (4.4%) | 21031 / 183050 (11.5%) | −231.5 | −229.0 | 0.38 |
| FOXA1 SRX176862 | MCF-7 Breast | 445 / 18305 (2.4%) | 15285 / 183050 (8.4%) | −231.4 | −228.9 | 0.29 |
| EP300 SRX2194266 | SUM 159PT Breast | 560 / 18305 (3.1%) | 17165 / 183050 (9.4%) | −230.9 | −228.4 | 0.33 |
| JADE3 DRX300415 | 293 Kidney | 1768 / 18305 (9.7%) | 7013 / 183050 (3.8%) | −230.8 | −228.3 | 2.52 |
| ESR1 SRX371469 | MCF-7 Breast | 336 / 18305 (1.8%) | 13370 / 183050 (7.3%) | −230.8 | −228.3 | 0.25 |
| JUNB SRX4192882 | MCF 10A Breast | 215 / 18305 (1.2%) | 11065 / 183050 (6.0%) | −229.8 | −227.2 | 0.19 |
| ESR1 SRX7624156 | MCF-7 Breast | 544 / 18305 (3.0%) | 16831 / 183050 (9.2%) | −228.6 | −226.1 | 0.32 |
| AR SRX10820651 | LNCAP Prostate | 416 / 18305 (2.3%) | 327 / 183050 (0.2%) | −228.5 | −226.0 | 12.72 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 576 / 18305 (3.1%) | 17331 / 183050 (9.5%) | −228.3 | −225.8 | 0.33 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1052 / 18305 (5.7%) | 2911 / 183050 (1.6%) | −228.2 | −225.7 | 3.61 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 658 / 18305 (3.6%) | 18610 / 183050 (10.2%) | −228.0 | −225.5 | 0.35 |
| JUN SRX7277180 | GM07492 Others | 228 / 18305 (1.2%) | 11224 / 183050 (6.1%) | −226.5 | −224.0 | 0.20 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 448 / 18305 (2.4%) | 15161 / 183050 (8.3%) | −225.9 | −223.4 | 0.30 |
| ESR1 SRX20282939 | MCF-7 Breast | 375 / 18305 (2.0%) | 13899 / 183050 (7.6%) | −225.5 | −223.0 | 0.27 |
| NR3C1 SRX2609662 | HASM2 Lung | 376 / 18305 (2.1%) | 13875 / 183050 (7.6%) | −224.1 | −221.6 | 0.27 |
| NR3C1 SRX2609665 | HASM2 Lung | 345 / 18305 (1.9%) | 13297 / 183050 (7.3%) | −223.0 | −220.5 | 0.26 |
| ESR1 SRX20282954 | MCF-7 Breast | 357 / 18305 (2.0%) | 13502 / 183050 (7.4%) | −222.9 | −220.4 | 0.26 |
| ESR1 SRX20282972 | MCF-7 Breast | 366 / 18305 (2.0%) | 13652 / 183050 (7.5%) | −222.6 | −220.1 | 0.27 |
| AGO2 SRX6783957 | Hep G2 Liver | 1392 / 18305 (7.6%) | 4866 / 183050 (2.7%) | −221.6 | −219.1 | 2.86 |
| JUN SRX883584 | MDA-MB-231 Breast | 524 / 18305 (2.9%) | 16265 / 183050 (8.9%) | −221.4 | −218.9 | 0.32 |
| FOSL2 SRX190296 | SK-N-SH Neural | 432 / 18305 (2.4%) | 14729 / 183050 (8.0%) | −220.8 | −218.3 | 0.29 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 667 / 18305 (3.6%) | 18483 / 183050 (10.1%) | −220.3 | −217.8 | 0.36 |
| AGO2 SRX6783958 | Hep G2 Liver | 1368 / 18305 (7.5%) | 4744 / 183050 (2.6%) | −220.3 | −217.8 | 2.88 |
| TCF12 SRX190356 | SK-N-SH Neural | 963 / 18305 (5.3%) | 22855 / 183050 (12.5%) | −219.8 | −217.3 | 0.42 |
| ESR1 SRX1531791 | MCF-7 Breast | 315 / 18305 (1.7%) | 12659 / 183050 (6.9%) | −219.7 | −217.3 | 0.25 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 664 / 18305 (3.6%) | 18397 / 183050 (10.1%) | −219.0 | −216.6 | 0.36 |
| YAP1 SRX5718140 | 293 Kidney | 584 / 18305 (3.2%) | 17144 / 183050 (9.4%) | −219.0 | −216.5 | 0.34 |
| STAT3 SRX150630 | MCF 10A Breast | 278 / 18305 (1.5%) | 11938 / 183050 (6.5%) | −218.2 | −215.8 | 0.23 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 257 / 18305 (1.4%) | 11514 / 183050 (6.3%) | −217.3 | −214.9 | 0.22 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 400 / 18305 (2.2%) | 14074 / 183050 (7.7%) | −217.2 | −214.8 | 0.28 |
| STAT3 SRX150479 | MCF 10A Breast | 285 / 18305 (1.6%) | 12013 / 183050 (6.6%) | −216.5 | −214.1 | 0.24 |
| JUND SRX190357 | SK-N-SH Neural | 413 / 18305 (2.3%) | 14256 / 183050 (7.8%) | −216.1 | −213.7 | 0.29 |
| Epitope tags SRX10549778 | K-562 Blood | 1289 / 18305 (7.0%) | 4349 / 183050 (2.4%) | −215.9 | −213.5 | 2.96 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 865 / 18305 (4.7%) | 21250 / 183050 (11.6%) | −214.7 | −212.3 | 0.41 |
| NR3C1 SRX2609659 | HASM2 Lung | 384 / 18305 (2.1%) | 13702 / 183050 (7.5%) | −214.3 | −211.9 | 0.28 |
| LEO1 SRX1873456 | SEM Blood | 1653 / 18305 (9.0%) | 6579 / 183050 (3.6%) | −213.8 | −211.4 | 2.51 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 954 / 18305 (5.2%) | 2565 / 183050 (1.4%) | −213.7 | −211.3 | 3.72 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 251 / 18305 (1.4%) | 11293 / 183050 (6.2%) | −213.6 | −211.2 | 0.22 |
| YAP1 SRX10119364 | MCF 10A Breast | 251 / 18305 (1.4%) | 11294 / 183050 (6.2%) | −213.6 | −211.2 | 0.22 |
| JUNB SRX10119383 | MCF 10A Breast | 198 / 18305 (1.1%) | 10260 / 183050 (5.6%) | −213.5 | −211.1 | 0.19 |
| NR3C1 SRX2609661 | HASM2 Lung | 360 / 18305 (2.0%) | 13247 / 183050 (7.2%) | −213.0 | −210.6 | 0.27 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 849 / 18305 (4.6%) | 20945 / 183050 (11.4%) | −212.8 | −210.4 | 0.41 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 322 / 18305 (1.8%) | 12574 / 183050 (6.9%) | −212.8 | −210.4 | 0.26 |
| FOXA1 SRX371481 | MCF-7 Breast | 378 / 18305 (2.1%) | 13548 / 183050 (7.4%) | −212.6 | −210.2 | 0.28 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 590 / 18305 (3.2%) | 17002 / 183050 (9.3%) | −212.0 | −209.6 | 0.35 |
| BMI1 SRX644729 | 293 Kidney | 303 / 18305 (1.7%) | 123 / 183050 (0.1%) | −211.7 | −209.3 | 24.63 |
| FOXA1 SRX176863 | MCF-7 Breast | 438 / 18305 (2.4%) | 14520 / 183050 (7.9%) | −211.2 | −208.8 | 0.30 |
| ESR1 SRX371467 | MCF-7 Breast | 363 / 18305 (2.0%) | 13218 / 183050 (7.2%) | −210.4 | −208.0 | 0.27 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 609 / 18305 (3.3%) | 1042 / 183050 (0.6%) | −209.7 | −207.3 | 5.84 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 455 / 18305 (2.5%) | 14744 / 183050 (8.1%) | −209.4 | −207.0 | 0.31 |
| ESR1 SRX194569 | MCF-7 Breast | 363 / 18305 (2.0%) | 13176 / 183050 (7.2%) | −209.0 | −206.7 | 0.28 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 421 / 18305 (2.3%) | 14163 / 183050 (7.7%) | −209.0 | −206.6 | 0.30 |
| TP53 SRX19538269 | U2OS Bone | 444 / 18305 (2.4%) | 475 / 183050 (0.3%) | −208.9 | −206.5 | 9.35 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 618 / 18305 (3.4%) | 17312 / 183050 (9.5%) | −208.4 | −206.0 | 0.36 |
| FOXA1 SRX371482 | MCF-7 Breast | 529 / 18305 (2.9%) | 15908 / 183050 (8.7%) | −208.2 | −205.8 | 0.33 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1065 / 18305 (5.8%) | 23851 / 183050 (13.0%) | −208.1 | −205.7 | 0.45 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1254 / 18305 (6.9%) | 26393 / 183050 (14.4%) | −206.6 | −204.2 | 0.48 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 453 / 18305 (2.5%) | 14617 / 183050 (8.0%) | −206.6 | −204.2 | 0.31 |
| NR3C1 SRX2609666 | HASM2 Lung | 315 / 18305 (1.7%) | 12246 / 183050 (6.7%) | −206.3 | −203.9 | 0.26 |
| VGLL1 SRX24602130 | BT-20 Breast | 348 / 18305 (1.9%) | 12806 / 183050 (7.0%) | −205.5 | −203.2 | 0.27 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 227 / 18305 (1.2%) | 10585 / 183050 (5.8%) | −205.1 | −202.7 | 0.21 |
| ESR1 SRX20282955 | MCF-7 Breast | 364 / 18305 (2.0%) | 13057 / 183050 (7.1%) | −204.7 | −202.4 | 0.28 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 618 / 18305 (3.4%) | 17181 / 183050 (9.4%) | −204.5 | −202.2 | 0.36 |
| JUNB SRX10119384 | MCF 10A Breast | 178 / 18305 (1.0%) | 9597 / 183050 (5.2%) | −204.3 | −202.0 | 0.19 |
| EP300 SRX150579 | HeLa Uterus | 198 / 18305 (1.1%) | 9989 / 183050 (5.5%) | −204.0 | −201.6 | 0.20 |
| PRRX1 SRX15235713 | Hs 578T Breast | 420 / 18305 (2.3%) | 13975 / 183050 (7.6%) | −203.7 | −201.4 | 0.30 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 626 / 18305 (3.4%) | 17273 / 183050 (9.4%) | −203.6 | −201.3 | 0.36 |
| ESR1 SRX20282973 | MCF-7 Breast | 429 / 18305 (2.3%) | 14121 / 183050 (7.7%) | −203.5 | −201.1 | 0.30 |
| JADE3 DRX234809 | 293 Kidney | 1163 / 18305 (6.4%) | 3804 / 183050 (2.1%) | −203.2 | −200.8 | 3.06 |
| FOXA1 SRX1161177 | MCF-7 Breast | 375 / 18305 (2.0%) | 13157 / 183050 (7.2%) | −201.8 | −199.5 | 0.29 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 190 / 18305 (1.0%) | 9749 / 183050 (5.3%) | −201.3 | −199.0 | 0.19 |
| JUN SRX2355072 | HAEC Cardiovascular | 459 / 18305 (2.5%) | 14534 / 183050 (7.9%) | −201.0 | −198.7 | 0.32 |
| ESR1 SRX10365535 | MCF-7 Breast | 274 / 18305 (1.5%) | 11344 / 183050 (6.2%) | −201.0 | −198.7 | 0.24 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 851 / 18305 (4.6%) | 2187 / 183050 (1.2%) | −200.3 | −198.1 | 3.89 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 877 / 18305 (4.8%) | 2318 / 183050 (1.3%) | −200.1 | −197.8 | 3.78 |
| ESR1 SRX4367192 | MCF-7 Breast | 762 / 18305 (4.2%) | 19196 / 183050 (10.5%) | −200.0 | −197.7 | 0.40 |
| ESR1 SRX371476 | MCF-7 Breast | 264 / 18305 (1.4%) | 11129 / 183050 (6.1%) | −200.0 | −197.7 | 0.24 |
| TP53 SRX396254 | Fibroblasts Others | 987 / 18305 (5.4%) | 2886 / 183050 (1.6%) | −199.7 | −197.4 | 3.42 |
| MEN1 SRX11712604 | K-562 Blood | 1578 / 18305 (8.6%) | 6368 / 183050 (3.5%) | −198.6 | −196.3 | 2.48 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 530 / 18305 (2.9%) | 15585 / 183050 (8.5%) | −198.3 | −196.0 | 0.34 |
| ESR1 SRX194572 | MCF-7 Breast | 217 / 18305 (1.2%) | 10192 / 183050 (5.6%) | −198.3 | −196.0 | 0.21 |
| FOXA1 SRX371483 | MCF-7 Breast | 429 / 18305 (2.3%) | 13944 / 183050 (7.6%) | −198.2 | −195.9 | 0.31 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 550 / 18305 (3.0%) | 15882 / 183050 (8.7%) | −197.7 | −195.4 | 0.35 |
| KAT7 DRX234808 | 293 Kidney | 888 / 18305 (4.9%) | 2403 / 183050 (1.3%) | −197.1 | −194.9 | 3.70 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 942 / 18305 (5.1%) | 21696 / 183050 (11.9%) | −197.1 | −194.9 | 0.43 |
| ESR1 SRX371468 | MCF-7 Breast | 221 / 18305 (1.2%) | 10219 / 183050 (5.6%) | −196.5 | −194.2 | 0.22 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 480 / 18305 (2.6%) | 14713 / 183050 (8.0%) | −196.1 | −193.8 | 0.33 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 496 / 18305 (2.7%) | 14872 / 183050 (8.1%) | −193.2 | −190.9 | 0.33 |
| BRD4 SRX736204 | 90-8TL Neural | 1002 / 18305 (5.5%) | 3044 / 183050 (1.7%) | −193.0 | −190.8 | 3.29 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 225 / 18305 (1.2%) | 10187 / 183050 (5.6%) | −192.9 | −190.6 | 0.22 |
| ESR1 SRX20282940 | MCF-7 Breast | 397 / 18305 (2.2%) | 13236 / 183050 (7.2%) | −192.7 | −190.5 | 0.30 |
| RAC1 SRX10365543 | MCF-7 Breast | 179 / 18305 (1.0%) | 9283 / 183050 (5.1%) | −192.6 | −190.4 | 0.19 |
| EP300 SRX2194265 | SUM 159PT Breast | 579 / 18305 (3.2%) | 16150 / 183050 (8.8%) | −192.3 | −190.1 | 0.36 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 481 / 18305 (2.6%) | 14573 / 183050 (8.0%) | −191.5 | −189.2 | 0.33 |
| WWTR1 SRX10119367 | MCF 10A Breast | 418 / 18305 (2.3%) | 13509 / 183050 (7.4%) | −190.4 | −188.2 | 0.31 |
| FOS SRX070879 | HUVEC Cardiovascular | 382 / 18305 (2.1%) | 12900 / 183050 (7.0%) | −190.1 | −187.9 | 0.30 |
| ESR1 SRX10365536 | MCF-7 Breast | 179 / 18305 (1.0%) | 9211 / 183050 (5.0%) | −190.1 | −187.9 | 0.19 |
| ESR1 SRX20282953 | MCF-7 Breast | 285 / 18305 (1.6%) | 11189 / 183050 (6.1%) | −189.4 | −187.2 | 0.25 |
| FOS SRX150664 | HUVEC Cardiovascular | 488 / 18305 (2.7%) | 14607 / 183050 (8.0%) | −189.2 | −187.0 | 0.33 |
| TP53 SRX19538270 | U2OS Bone | 414 / 18305 (2.3%) | 468 / 183050 (0.3%) | −188.7 | −186.5 | 8.85 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1252 / 18305 (6.8%) | 4521 / 183050 (2.5%) | −188.7 | −186.4 | 2.77 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 563 / 18305 (3.1%) | 15759 / 183050 (8.6%) | −188.3 | −186.1 | 0.36 |
| ESR1 SRX20282971 | MCF-7 Breast | 359 / 18305 (2.0%) | 12449 / 183050 (6.8%) | −188.3 | −186.0 | 0.29 |
| ESR1 SRX2881002 | MCF-7 Breast | 340 / 18305 (1.9%) | 12121 / 183050 (6.6%) | −188.2 | −186.0 | 0.28 |
| FOXA1 SRX4815197 | MCF-7 Breast | 955 / 18305 (5.2%) | 21524 / 183050 (11.8%) | −188.1 | −185.9 | 0.44 |
| TLE3 SRX4815194 | SUM 149PT Breast | 255 / 18305 (1.4%) | 10604 / 183050 (5.8%) | −188.1 | −185.8 | 0.24 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1428 / 18305 (7.8%) | 5610 / 183050 (3.1%) | −187.8 | −185.5 | 2.55 |
| KMT2A SRX2323891 | 293 Kidney | 1091 / 18305 (6.0%) | 3603 / 183050 (2.0%) | −187.6 | −185.4 | 3.03 |
| JUN SRX6582163 | BJ-5ta Epidermis | 461 / 18305 (2.5%) | 14102 / 183050 (7.7%) | −187.1 | −184.8 | 0.33 |
| ESR1 SRX330067 | MCF-7 Breast | 332 / 18305 (1.8%) | 11935 / 183050 (6.5%) | −186.8 | −184.6 | 0.28 |
| STAT1 SRX23678708 | K-562 Blood | 1669 / 18305 (9.1%) | 7178 / 183050 (3.9%) | −186.5 | −184.3 | 2.33 |
| ESR1 SRX371470 | ZR-75-1 Breast | 352 / 18305 (1.9%) | 12273 / 183050 (6.7%) | −186.5 | −184.3 | 0.29 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 664 / 18305 (3.6%) | 17235 / 183050 (9.4%) | −186.3 | −184.1 | 0.39 |
| TP53 SRX19538282 | Osteoblasts Bone | 368 / 18305 (2.0%) | 343 / 183050 (0.2%) | −186.3 | −184.1 | 10.73 |
| GATA3 SRX190239 | MCF-7 Breast | 581 / 18305 (3.2%) | 15964 / 183050 (8.7%) | −186.1 | −183.9 | 0.36 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 568 / 18305 (3.1%) | 15759 / 183050 (8.6%) | −186.0 | −183.8 | 0.36 |
| STAT3 SRX150536 | MCF 10A Breast | 412 / 18305 (2.3%) | 13244 / 183050 (7.2%) | −185.4 | −183.2 | 0.31 |
| ING2 SRX286201 | RKO Digestive tract | 1537 / 18305 (8.4%) | 6346 / 183050 (3.5%) | −185.2 | −183.0 | 2.42 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 541 / 18305 (3.0%) | 15300 / 183050 (8.4%) | −185.0 | −182.8 | 0.35 |
| RAC1 SRX10365541 | MCF-7 Breast | 186 / 18305 (1.0%) | 9197 / 183050 (5.0%) | −184.9 | −182.8 | 0.20 |
| FOXA1 SRX1161175 | MCF-7 Breast | 287 / 18305 (1.6%) | 11080 / 183050 (6.1%) | −184.7 | −182.5 | 0.26 |
| YAP1 SRX1038945 | IMR-90 Lung | 263 / 18305 (1.4%) | 10644 / 183050 (5.8%) | −184.7 | −182.5 | 0.25 |
| ESR1 SRX2881000 | MCF-7 Breast | 322 / 18305 (1.8%) | 11679 / 183050 (6.4%) | −184.2 | −182.0 | 0.28 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 559 / 18305 (3.1%) | 1010 / 183050 (0.6%) | −184.1 | −181.9 | 5.53 |
| FOXA1 SRX1161173 | MCF-7 Breast | 313 / 18305 (1.7%) | 11491 / 183050 (6.3%) | −183.2 | −181.1 | 0.27 |
| ESR1 SRX371471 | ZR-75-1 Breast | 433 / 18305 (2.4%) | 13512 / 183050 (7.4%) | −183.1 | −180.9 | 0.32 |
| FOXA1 SRX371480 | MCF-7 Breast | 256 / 18305 (1.4%) | 10462 / 183050 (5.7%) | −182.9 | −180.7 | 0.24 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 503 / 18305 (2.7%) | 14625 / 183050 (8.0%) | −182.8 | −180.6 | 0.34 |
| SSRP1 SRX3436567 | HT-1080 Bone | 446 / 18305 (2.4%) | 600 / 183050 (0.3%) | −182.5 | −180.3 | 7.43 |
| TLE3 SRX4815191 | MCF-7 Breast | 379 / 18305 (2.1%) | 12598 / 183050 (6.9%) | −182.5 | −180.3 | 0.30 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 868 / 18305 (4.7%) | 2457 / 183050 (1.3%) | −182.5 | −180.3 | 3.53 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 577 / 18305 (3.2%) | 1095 / 183050 (0.6%) | −182.3 | −180.1 | 5.27 |
| FOXA1 SRX1161176 | MCF-7 Breast | 387 / 18305 (2.1%) | 12711 / 183050 (6.9%) | −181.9 | −179.7 | 0.30 |
| JUND SRX150408 | HeLa Uterus | 321 / 18305 (1.8%) | 11552 / 183050 (6.3%) | −180.7 | −178.5 | 0.28 |
| ARID1A SRX5089376 | MCF-7 Breast | 334 / 18305 (1.8%) | 11774 / 183050 (6.4%) | −180.6 | −178.5 | 0.28 |
| WWTR1 SRX10119378 | MCF 10A Breast | 403 / 18305 (2.2%) | 12927 / 183050 (7.1%) | −180.4 | −178.2 | 0.31 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 258 / 18305 (1.4%) | 10424 / 183050 (5.7%) | −180.3 | −178.2 | 0.25 |
| FOXA1 SRX3931044 | MCF-7 Breast | 867 / 18305 (4.7%) | 19955 / 183050 (10.9%) | −179.8 | −177.6 | 0.43 |
| ESR1 SRX11120903 | MCF-7 Breast | 324 / 18305 (1.8%) | 11568 / 183050 (6.3%) | −179.6 | −177.4 | 0.28 |
| EP300 ERX626821 | U-937 Blood | 1333 / 18305 (7.3%) | 5162 / 183050 (2.8%) | −179.2 | −177.0 | 2.58 |
| EP300 ERX626811 | U-937 Blood | 1339 / 18305 (7.3%) | 5201 / 183050 (2.8%) | −179.0 | −176.9 | 2.57 |
| DAXX SRX1021630 | PC-3 Prostate | 380 / 18305 (2.1%) | 12486 / 183050 (6.8%) | −178.5 | −176.3 | 0.30 |
| CEBPB SRX150632 | HeLa Uterus | 890 / 18305 (4.9%) | 20229 / 183050 (11.1%) | −178.5 | −176.3 | 0.44 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1327 / 18305 (7.2%) | 5142 / 183050 (2.8%) | −178.2 | −176.0 | 2.58 |
| GATA3 SRX176864 | MCF-7 Breast | 292 / 18305 (1.6%) | 10957 / 183050 (6.0%) | −177.9 | −175.8 | 0.27 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 366 / 18305 (2.0%) | 12229 / 183050 (6.7%) | −177.8 | −175.7 | 0.30 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 308 / 18305 (1.7%) | 11231 / 183050 (6.1%) | −177.8 | −175.6 | 0.27 |
| ARID1A SRX5679787 | 12Z Others | 122 / 18305 (0.7%) | 7678 / 183050 (4.2%) | −177.7 | −175.6 | 0.16 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 547 / 18305 (3.0%) | 15129 / 183050 (8.3%) | −177.4 | −175.3 | 0.36 |
| PBX3 SRX190343 | SK-N-SH Neural | 822 / 18305 (4.5%) | 19211 / 183050 (10.5%) | −177.2 | −175.1 | 0.43 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 514 / 18305 (2.8%) | 14605 / 183050 (8.0%) | −177.2 | −175.0 | 0.35 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 366 / 18305 (2.0%) | 12204 / 183050 (6.7%) | −177.1 | −175.0 | 0.30 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 900 / 18305 (4.9%) | 20310 / 183050 (11.1%) | −176.9 | −174.8 | 0.44 |
| STAT3 SRX2020842 | HCC70 Breast | 700 / 18305 (3.8%) | 17422 / 183050 (9.5%) | −176.8 | −174.7 | 0.40 |
| ESR1 SRX20282938 | MCF-7 Breast | 301 / 18305 (1.6%) | 11078 / 183050 (6.1%) | −176.8 | −174.6 | 0.27 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 428 / 18305 (2.3%) | 13198 / 183050 (7.2%) | −176.2 | −174.0 | 0.32 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 264 / 18305 (1.4%) | 10399 / 183050 (5.7%) | −176.1 | −174.0 | 0.25 |
| IRF3 SRX11453858 | Hep G2 Liver | 263 / 18305 (1.4%) | 123 / 183050 (0.1%) | −176.1 | −174.0 | 21.38 |
| ESR1 SRX20282946 | MCF-7 Breast | 223 / 18305 (1.2%) | 9623 / 183050 (5.3%) | −175.3 | −173.2 | 0.23 |
| NR3C1 SRX10977372 | A549 Lung | 204 / 18305 (1.1%) | 9261 / 183050 (5.1%) | −175.1 | −173.0 | 0.22 |
| JUNB SRX10119385 | MCF 10A Breast | 153 / 18305 (0.8%) | 8251 / 183050 (4.5%) | −174.9 | −172.8 | 0.19 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 502 / 18305 (2.7%) | 14331 / 183050 (7.8%) | −174.7 | −172.6 | 0.35 |
| ESR1 SRX3110725 | MCF-7 Breast | 350 / 18305 (1.9%) | 11850 / 183050 (6.5%) | −174.4 | −172.3 | 0.30 |
| ARID1A SRX5679788 | 12Z Others | 140 / 18305 (0.8%) | 7951 / 183050 (4.3%) | −173.8 | −171.7 | 0.18 |
| ESR1 SRX330069 | MCF-7 Breast | 231 / 18305 (1.3%) | 9708 / 183050 (5.3%) | −173.2 | −171.1 | 0.24 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 562 / 18305 (3.1%) | 15198 / 183050 (8.3%) | −172.8 | −170.7 | 0.37 |
| NFYB SRX16608147 | HeLa Uterus | 293 / 18305 (1.6%) | 197 / 183050 (0.1%) | −172.1 | −170.0 | 14.87 |
| ESR1 SRX371477 | MCF-7 Breast | 191 / 18305 (1.0%) | 8913 / 183050 (4.9%) | −171.9 | −169.8 | 0.21 |
| JUN SRX6582165 | BJ-5ta Epidermis | 763 / 18305 (4.2%) | 18154 / 183050 (9.9%) | −171.9 | −169.8 | 0.42 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1327 / 18305 (7.2%) | 5251 / 183050 (2.9%) | −171.7 | −169.6 | 2.53 |
| ESR1 SRX3123829 | MCF-7 Breast | 214 / 18305 (1.2%) | 9343 / 183050 (5.1%) | −171.7 | −169.6 | 0.23 |
| STAT3 SRX4192888 | MCF 10A Breast | 171 / 18305 (0.9%) | 8515 / 183050 (4.7%) | −171.7 | −169.6 | 0.20 |
| NFIC SRX190336 | SK-N-SH Neural | 556 / 18305 (3.0%) | 15062 / 183050 (8.2%) | −171.6 | −169.5 | 0.37 |
| MYC SRX13134693 | 293 Kidney | 1411 / 18305 (7.7%) | 5786 / 183050 (3.2%) | −171.5 | −169.4 | 2.44 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 774 / 18305 (4.2%) | 18291 / 183050 (10.0%) | −171.3 | −169.2 | 0.42 |
| AR SRX1067066 | LHSAR Prostate | 855 / 18305 (4.7%) | 19427 / 183050 (10.6%) | −170.7 | −168.6 | 0.44 |
| GATA3 SRX5057632 | MCF-7 Breast | 265 / 18305 (1.4%) | 10248 / 183050 (5.6%) | −170.7 | −168.6 | 0.26 |
| NR3C1 SRX10976921 | A549 Lung | 268 / 18305 (1.5%) | 10304 / 183050 (5.6%) | −170.7 | −168.6 | 0.26 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 404 / 18305 (2.2%) | 12616 / 183050 (6.9%) | −170.5 | −168.5 | 0.32 |
| STAT1 SRX23678707 | K-562 Blood | 1529 / 18305 (8.4%) | 6572 / 183050 (3.6%) | −170.3 | −168.2 | 2.33 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 366 / 18305 (2.0%) | 11968 / 183050 (6.5%) | −169.9 | −167.8 | 0.31 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 626 / 18305 (3.4%) | 16051 / 183050 (8.8%) | −169.6 | −167.5 | 0.39 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 651 / 18305 (3.6%) | 1520 / 183050 (0.8%) | −169.4 | −167.3 | 4.28 |
| JUND SRX699738 | HCASMC Cardiovascular | 559 / 18305 (3.1%) | 15011 / 183050 (8.2%) | −169.0 | −166.9 | 0.37 |
| ESR1 SRX8537722 | MCF-7 Breast | 369 / 18305 (2.0%) | 11987 / 183050 (6.5%) | −169.0 | −166.9 | 0.31 |
| MLLT6 DRX059637 | 293 Kidney | 446 / 18305 (2.4%) | 672 / 183050 (0.4%) | −168.8 | −166.7 | 6.64 |
| ESR1 SRX371474 | BT-474 Breast | 172 / 18305 (0.9%) | 8453 / 183050 (4.6%) | −168.7 | −166.7 | 0.20 |
| ESR1 SRX371475 | BT-474 Breast | 192 / 18305 (1.0%) | 8839 / 183050 (4.8%) | −168.7 | −166.7 | 0.22 |
| NR3C1 SRX10977357 | A549 Lung | 234 / 18305 (1.3%) | 9614 / 183050 (5.3%) | −168.3 | −166.3 | 0.24 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 637 / 18305 (3.5%) | 1467 / 183050 (0.8%) | −168.0 | −166.0 | 4.34 |
| AR SRX1067067 | LHSAR Prostate | 692 / 18305 (3.8%) | 16964 / 183050 (9.3%) | −167.8 | −165.7 | 0.41 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 377 / 18305 (2.1%) | 12056 / 183050 (6.6%) | −167.1 | −165.1 | 0.31 |
| ESR1 SRX10365558 | MCF-7 Breast | 267 / 18305 (1.5%) | 10174 / 183050 (5.6%) | −167.0 | −165.0 | 0.26 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 626 / 18305 (3.4%) | 1426 / 183050 (0.8%) | −166.9 | −164.9 | 4.39 |
| STAT5B SRX831881 | CD8+ T cells Blood | 269 / 18305 (1.5%) | 157 / 183050 (0.1%) | −166.9 | −164.9 | 17.13 |
| STAT3 SRX8520800 | SUM 159PT Breast | 225 / 18305 (1.2%) | 9404 / 183050 (5.1%) | −166.9 | −164.8 | 0.24 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 427 / 18305 (2.3%) | 12862 / 183050 (7.0%) | −166.8 | −164.7 | 0.33 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 521 / 18305 (2.8%) | 14341 / 183050 (7.8%) | −166.6 | −164.5 | 0.36 |
| JUN SRX2355073 | HAEC Cardiovascular | 504 / 18305 (2.8%) | 14072 / 183050 (7.7%) | −166.5 | −164.5 | 0.36 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 188 / 18305 (1.0%) | 8678 / 183050 (4.7%) | −165.9 | −163.9 | 0.22 |
| ESR1 SRX20282959 | MCF-7 Breast | 152 / 18305 (0.8%) | 7967 / 183050 (4.4%) | −165.8 | −163.7 | 0.19 |
| FOXA1 SRX1787653 | MCF-7 Breast | 342 / 18305 (1.9%) | 11418 / 183050 (6.2%) | −165.4 | −163.4 | 0.30 |
| EP300 SRX10976625 | A549 Lung | 220 / 18305 (1.2%) | 9249 / 183050 (5.1%) | −164.9 | −162.8 | 0.24 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 412 / 18305 (2.3%) | 12540 / 183050 (6.9%) | −164.5 | −162.4 | 0.33 |
| JUN SRX6582164 | BJ-5ta Epidermis | 511 / 18305 (2.8%) | 14105 / 183050 (7.7%) | −164.3 | −162.2 | 0.36 |
| ARID1A SRX5089379 | MCF-7 Breast | 410 / 18305 (2.2%) | 12498 / 183050 (6.8%) | −164.2 | −162.2 | 0.33 |
| FOS SRX3322636 | MCF-7 Breast | 255 / 18305 (1.4%) | 9864 / 183050 (5.4%) | −164.0 | −162.0 | 0.26 |
| NR2F2 SRX190293 | MCF-7 Breast | 440 / 18305 (2.4%) | 12973 / 183050 (7.1%) | −163.9 | −161.9 | 0.34 |
| TEAD1 SRX3401272 | MCF-7 Breast | 308 / 18305 (1.7%) | 10788 / 183050 (5.9%) | −163.9 | −161.8 | 0.29 |
| ESR1 SRX330070 | MCF-7 Breast | 204 / 18305 (1.1%) | 8913 / 183050 (4.9%) | −163.6 | −161.5 | 0.23 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 388 / 18305 (2.1%) | 12105 / 183050 (6.6%) | −163.2 | −161.1 | 0.32 |
| ESR1 SRX1012629 | MCF-7 Breast | 251 / 18305 (1.4%) | 9762 / 183050 (5.3%) | −163.1 | −161.1 | 0.26 |
| MED1 SRX4937338 | HCT 116 Digestive tract | 1486 / 18305 (8.1%) | 6435 / 183050 (3.5%) | −162.9 | −160.9 | 2.31 |
| WWTR1 SRX10119368 | MCF 10A Breast | 272 / 18305 (1.5%) | 10117 / 183050 (5.5%) | −162.6 | −160.5 | 0.27 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 498 / 18305 (2.7%) | 13829 / 183050 (7.6%) | −162.2 | −160.2 | 0.36 |
| ESR1 SRX1469949 | MCF-7 Breast | 228 / 18305 (1.2%) | 9301 / 183050 (5.1%) | −161.8 | −159.7 | 0.25 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 386 / 18305 (2.1%) | 12015 / 183050 (6.6%) | −161.4 | −159.3 | 0.32 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 348 / 18305 (1.9%) | 11367 / 183050 (6.2%) | −160.9 | −158.9 | 0.31 |
| RELA SRX7055007 | HAEC Cardiovascular | 755 / 18305 (4.1%) | 17601 / 183050 (9.6%) | −160.5 | −158.5 | 0.43 |
| ESR1 SRX2943591 | MCF-7 Breast | 293 / 18305 (1.6%) | 10417 / 183050 (5.7%) | −160.4 | −158.4 | 0.28 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 704 / 18305 (3.8%) | 1861 / 183050 (1.0%) | −160.1 | −158.1 | 3.78 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 379 / 18305 (2.1%) | 11847 / 183050 (6.5%) | −159.8 | −157.8 | 0.32 |
| EP300 SRX176885 | MCF-7 Breast | 210 / 18305 (1.1%) | 8908 / 183050 (4.9%) | −159.8 | −157.8 | 0.24 |
| RELA SRX5938177 | FaDu Others | 378 / 18305 (2.1%) | 11823 / 183050 (6.5%) | −159.6 | −157.5 | 0.32 |
| TLE3 SRX4815192 | MCF-7 Breast | 386 / 18305 (2.1%) | 11937 / 183050 (6.5%) | −159.2 | −157.2 | 0.32 |
| NR3C1 SRX17639412 | A549 Lung | 468 / 18305 (2.6%) | 13242 / 183050 (7.2%) | −159.0 | −157.0 | 0.35 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1113 / 18305 (6.1%) | 4147 / 183050 (2.3%) | −158.8 | −156.8 | 2.68 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1184 / 18305 (6.5%) | 23437 / 183050 (12.8%) | −158.6 | −156.6 | 0.51 |
| JUNB SRX2443774 | A549 Lung | 161 / 18305 (0.9%) | 7931 / 183050 (4.3%) | −158.4 | −156.4 | 0.20 |
| SMARCA4 SRX5982364 | A549 Lung | 113 / 18305 (0.6%) | 6937 / 183050 (3.8%) | −158.0 | −156.0 | 0.16 |
| CXXC1 SRX1424886 | SEM Blood | 1515 / 18305 (8.3%) | 6728 / 183050 (3.7%) | −157.8 | −155.8 | 2.25 |
| NR3C1 SRX8520802 | HCC1187 Breast | 303 / 18305 (1.7%) | 10471 / 183050 (5.7%) | −156.8 | −154.8 | 0.29 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 203 / 18305 (1.1%) | 8685 / 183050 (4.7%) | −156.7 | −154.7 | 0.23 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 407 / 18305 (2.2%) | 12195 / 183050 (6.7%) | −156.7 | −154.7 | 0.33 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 337 / 18305 (1.8%) | 11042 / 183050 (6.0%) | −156.5 | −154.5 | 0.31 |
| FOXA1 SRX5323843 | MCF-7 Breast | 215 / 18305 (1.2%) | 8899 / 183050 (4.9%) | −156.4 | −154.4 | 0.24 |
| JUN SRX150358 | HUVEC Cardiovascular | 262 / 18305 (1.4%) | 9740 / 183050 (5.3%) | −156.2 | −154.2 | 0.27 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 942 / 18305 (5.1%) | 3183 / 183050 (1.7%) | −156.2 | −154.2 | 2.96 |
| GATA1 SRX4172744 | HCT 116 Digestive tract | 1588 / 18305 (8.7%) | 7264 / 183050 (4.0%) | −155.8 | −153.8 | 2.19 |
| DOT1L DRX411731 | 293 Kidney | 319 / 18305 (1.7%) | 319 / 183050 (0.2%) | −155.7 | −153.7 | 10.00 |
| ESR1 SRX2513520 | MCF-7 Breast | 255 / 18305 (1.4%) | 9588 / 183050 (5.2%) | −155.3 | −153.3 | 0.27 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 407 / 18305 (2.2%) | 12136 / 183050 (6.6%) | −155.1 | −153.1 | 0.34 |
| EP300 SRX10976215 | A549 Lung | 384 / 18305 (2.1%) | 11756 / 183050 (6.4%) | −154.8 | −152.8 | 0.33 |
| FOSL2 SRX190204 | A549 Lung | 419 / 18305 (2.3%) | 12317 / 183050 (6.7%) | −154.7 | −152.7 | 0.34 |
| IRF3 SRX11453861 | Hep G2 Liver | 235 / 18305 (1.3%) | 116 / 183050 (0.1%) | −154.7 | −152.7 | 20.26 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 207 / 18305 (1.1%) | 8696 / 183050 (4.8%) | −154.6 | −152.6 | 0.24 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 543 / 18305 (3.0%) | 14242 / 183050 (7.8%) | −154.6 | −152.6 | 0.38 |
| SMAD3 SRX366168 | NCI-H441 Lung | 366 / 18305 (2.0%) | 11449 / 183050 (6.3%) | −154.4 | −152.4 | 0.32 |
| RELA SRX7054663 | HAEC Cardiovascular | 361 / 18305 (2.0%) | 11356 / 183050 (6.2%) | −154.1 | −152.1 | 0.32 |
| CHD1 SRX116454 | hESC H1 Pluripotent stem cell | 864 / 18305 (4.7%) | 2774 / 183050 (1.5%) | −153.9 | −152.0 | 3.11 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1405 / 18305 (7.7%) | 6078 / 183050 (3.3%) | −153.9 | −151.9 | 2.31 |
| EP300 SRX190219 | SK-N-SH Neural | 410 / 18305 (2.2%) | 12142 / 183050 (6.6%) | −153.8 | −151.8 | 0.34 |
| ESR1 SRX10365532 | MCF-7 Breast | 237 / 18305 (1.3%) | 9219 / 183050 (5.0%) | −153.8 | −151.8 | 0.26 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 311 / 18305 (1.7%) | 10512 / 183050 (5.7%) | −153.8 | −151.8 | 0.30 |
| CEBPB SRX2194250 | SUM 159PT Breast | 511 / 18305 (2.8%) | 13718 / 183050 (7.5%) | −153.6 | −151.6 | 0.37 |
| ESR1 SRX2513517 | MCF-7 Breast | 283 / 18305 (1.5%) | 10020 / 183050 (5.5%) | −153.5 | −151.6 | 0.28 |
| ARID1A SRX5089385 | MCF-7 Breast | 321 / 18305 (1.8%) | 10660 / 183050 (5.8%) | −153.2 | −151.2 | 0.30 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 197 / 18305 (1.1%) | 8467 / 183050 (4.6%) | −153.1 | −151.2 | 0.23 |
| SMARCA4 SRX5982340 | A549 Lung | 160 / 18305 (0.9%) | 7756 / 183050 (4.2%) | −153.1 | −151.1 | 0.21 |
| FOXA1 SRX11222442 | MCF-7 Breast | 292 / 18305 (1.6%) | 10161 / 183050 (5.6%) | −153.0 | −151.1 | 0.29 |
| RBFOX2 SRX4708082 | K-562 Blood | 2432 / 18305 (13.3%) | 13429 / 183050 (7.3%) | −153.0 | −151.0 | 1.81 |
| ESR1 SRX10365533 | MCF-7 Breast | 203 / 18305 (1.1%) | 8569 / 183050 (4.7%) | −152.8 | −150.9 | 0.24 |
| FOXA1 SRX028634 | MCF-7 Breast | 212 / 18305 (1.2%) | 8731 / 183050 (4.8%) | −152.8 | −150.8 | 0.24 |
| FOXA1 SRX100454 | T-47D Breast | 573 / 18305 (3.1%) | 14630 / 183050 (8.0%) | −152.8 | −150.8 | 0.39 |
| TP53 SRX19538271 | U2OS Bone | 585 / 18305 (3.2%) | 1361 / 183050 (0.7%) | −152.6 | −150.7 | 4.30 |
| FOXA1 SRX1447317 | MCF-7 Breast | 277 / 18305 (1.5%) | 9889 / 183050 (5.4%) | −152.6 | −150.7 | 0.28 |
| NR3C1 SRX10977373 | A549 Lung | 223 / 18305 (1.2%) | 8927 / 183050 (4.9%) | −152.6 | −150.6 | 0.25 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 538 / 18305 (2.9%) | 14093 / 183050 (7.7%) | −152.5 | −150.6 | 0.38 |
| ESR1 SRX1469951 | MCF-7 Breast | 215 / 18305 (1.2%) | 8773 / 183050 (4.8%) | −152.2 | −150.3 | 0.25 |
| PGR SRX1012655 | MCF-7 Breast | 275 / 18305 (1.5%) | 9839 / 183050 (5.4%) | −152.1 | −150.2 | 0.28 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 860 / 18305 (4.7%) | 2778 / 183050 (1.5%) | −151.9 | −150.0 | 3.10 |
| ESR1 SRX1531796 | MCF-7 Breast | 226 / 18305 (1.2%) | 8960 / 183050 (4.9%) | −151.8 | −149.9 | 0.25 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 339 / 18305 (1.9%) | 10915 / 183050 (6.0%) | −151.7 | −149.8 | 0.31 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 420 / 18305 (2.3%) | 12232 / 183050 (6.7%) | −151.7 | −149.8 | 0.34 |
| FOXA1 SRX11222437 | MCF-7 Breast | 320 / 18305 (1.7%) | 10589 / 183050 (5.8%) | −151.5 | −149.6 | 0.30 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 607 / 18305 (3.3%) | 15086 / 183050 (8.2%) | −151.4 | −149.5 | 0.40 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 322 / 18305 (1.8%) | 10615 / 183050 (5.8%) | −151.4 | −149.4 | 0.30 |
| EP300 SRX1012648 | MCF-7 Breast | 203 / 18305 (1.1%) | 8523 / 183050 (4.7%) | −151.3 | −149.4 | 0.24 |
| RELA SRX7054617 | HAEC Cardiovascular | 516 / 18305 (2.8%) | 13708 / 183050 (7.5%) | −151.1 | −149.2 | 0.38 |
| Epitope tags SRX10549777 | K-562 Blood | 2505 / 18305 (13.7%) | 14040 / 183050 (7.7%) | −151.1 | −149.2 | 1.78 |
| SMARCA4 SRX5982341 | A549 Lung | 117 / 18305 (0.6%) | 6825 / 183050 (3.7%) | −151.0 | −149.1 | 0.17 |
| KMT2B DRX059614 | HB1119 Blood | 919 / 18305 (5.0%) | 3123 / 183050 (1.7%) | −151.0 | −149.1 | 2.94 |
| ESR1 SRX8537723 | MCF-7 Breast | 346 / 18305 (1.9%) | 10999 / 183050 (6.0%) | −150.9 | −149.0 | 0.31 |
| ESR1 SRX1012632 | MCF-7 Breast | 212 / 18305 (1.2%) | 8675 / 183050 (4.7%) | −150.8 | −148.9 | 0.24 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 785 / 18305 (4.3%) | 17628 / 183050 (9.6%) | −150.5 | −148.5 | 0.45 |
| CDK9 SRX7366783 | MCF-7 Breast | 248 / 18305 (1.4%) | 154 / 183050 (0.1%) | −150.4 | −148.4 | 16.10 |
| TEAD1 SRX716558 | SF268 Neural | 207 / 18305 (1.1%) | 8564 / 183050 (4.7%) | −150.3 | −148.4 | 0.24 |
| TCF21 DRX190655 | HCF Cardiovascular | 714 / 18305 (3.9%) | 16594 / 183050 (9.1%) | −149.9 | −147.9 | 0.43 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 393 / 18305 (2.1%) | 11728 / 183050 (6.4%) | −149.8 | −147.8 | 0.34 |
| NKX2-1 SRX2164786 | A549 Lung | 720 / 18305 (3.9%) | 16673 / 183050 (9.1%) | −149.7 | −147.8 | 0.43 |
| SMARCA2 SRX5982361 | A549 Lung | 126 / 18305 (0.7%) | 6965 / 183050 (3.8%) | −149.5 | −147.5 | 0.18 |
| ESR1 SRX330068 | MCF-7 Breast | 201 / 18305 (1.1%) | 8426 / 183050 (4.6%) | −149.4 | −147.5 | 0.24 |
| FOXA1 SRX3923514 | MCF-7 Breast | 462 / 18305 (2.5%) | 12804 / 183050 (7.0%) | −149.3 | −147.3 | 0.36 |
| EP300 SRX176883 | MCF-7 Breast | 199 / 18305 (1.1%) | 8383 / 183050 (4.6%) | −149.3 | −147.3 | 0.24 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 581 / 18305 (3.2%) | 14618 / 183050 (8.0%) | −149.2 | −147.3 | 0.40 |
| TAL1 SRX393516 | Primary endothelial cells Cardiovascular | 524 / 18305 (2.9%) | 13756 / 183050 (7.5%) | −149.2 | −147.2 | 0.38 |
| EP300 SRX100540 | SK-N-SH Neural | 631 / 18305 (3.4%) | 15351 / 183050 (8.4%) | −149.0 | −147.1 | 0.41 |
| ZNF711 SRX7805363 | 293 Kidney | 1576 / 18305 (8.6%) | 7334 / 183050 (4.0%) | −148.8 | −146.9 | 2.15 |
| FOXA1 SRX5203303 | MCF-7 Breast | 142 / 18305 (0.8%) | 7274 / 183050 (4.0%) | −148.8 | −146.9 | 0.20 |
| FOS SRX3322637 | MCF-7 Breast | 224 / 18305 (1.2%) | 8827 / 183050 (4.8%) | −148.7 | −146.8 | 0.25 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 359 / 18305 (2.0%) | 11138 / 183050 (6.1%) | −148.6 | −146.7 | 0.32 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 476 / 18305 (2.6%) | 12994 / 183050 (7.1%) | −148.5 | −146.6 | 0.37 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 321 / 18305 (1.8%) | 10494 / 183050 (5.7%) | −148.2 | −146.2 | 0.31 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 801 / 18305 (4.4%) | 17759 / 183050 (9.7%) | −148.1 | −146.2 | 0.45 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 529 / 18305 (2.9%) | 13792 / 183050 (7.5%) | −148.0 | −146.1 | 0.38 |
| FOXA1 SRX028635 | MCF-7 Breast | 220 / 18305 (1.2%) | 8727 / 183050 (4.8%) | −147.9 | −146.0 | 0.25 |
| ESR1 SRX2912055 | MCF-7 Breast | 163 / 18305 (0.9%) | 7658 / 183050 (4.2%) | −147.9 | −146.0 | 0.21 |
| CHD1 SRX186771 | K-562 Blood | 749 / 18305 (4.1%) | 2225 / 183050 (1.2%) | −147.9 | −145.9 | 3.37 |
| FOXA1 SRX1787655 | MCF-7 Breast | 220 / 18305 (1.2%) | 8725 / 183050 (4.8%) | −147.8 | −145.9 | 0.25 |
| ESR1 SRX5323871 | MCF-7 Breast | 481 / 18305 (2.6%) | 13046 / 183050 (7.1%) | −147.8 | −145.8 | 0.37 |
| FOXA1 SRX1161174 | MCF-7 Breast | 473 / 18305 (2.6%) | 12919 / 183050 (7.1%) | −147.7 | −145.8 | 0.37 |
| RELA SRX7054609 | HAEC Cardiovascular | 351 / 18305 (1.9%) | 10972 / 183050 (6.0%) | −147.6 | −145.7 | 0.32 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 484 / 18305 (2.6%) | 13084 / 183050 (7.1%) | −147.5 | −145.6 | 0.37 |
| EP300 SRX2194268 | SUM 159PT Breast | 169 / 18305 (0.9%) | 7762 / 183050 (4.2%) | −147.5 | −145.6 | 0.22 |
| Epitope tags SRX2745846 | MCF 10A Breast | 274 / 18305 (1.5%) | 9671 / 183050 (5.3%) | −147.5 | −145.5 | 0.28 |
| FOXA1 SRX11222441 | MCF-7 Breast | 351 / 18305 (1.9%) | 10953 / 183050 (6.0%) | −147.1 | −145.2 | 0.32 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 412 / 18305 (2.3%) | 11938 / 183050 (6.5%) | −147.1 | −145.2 | 0.35 |
| CHD1 SRX116417 | K-562 Blood | 711 / 18305 (3.9%) | 2037 / 183050 (1.1%) | −146.9 | −145.0 | 3.49 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 873 / 18305 (4.8%) | 2918 / 183050 (1.6%) | −146.8 | −144.9 | 2.99 |
| KAT7 DRX300414 | 293 Kidney | 637 / 18305 (3.5%) | 1664 / 183050 (0.9%) | −146.7 | −144.8 | 3.83 |
| RELA SRX7054657 | HAEC Cardiovascular | 494 / 18305 (2.7%) | 13205 / 183050 (7.2%) | −146.7 | −144.8 | 0.37 |
| NR3C1 SRX10976392 | A549 Lung | 192 / 18305 (1.0%) | 8174 / 183050 (4.5%) | −146.7 | −144.8 | 0.23 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1379 / 18305 (7.5%) | 6058 / 183050 (3.3%) | −146.4 | −144.5 | 2.28 |
| WWTR1 SRX10119390 | MDA-MB-231 Breast | 150 / 18305 (0.8%) | 7361 / 183050 (4.0%) | −146.3 | −144.4 | 0.20 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 416 / 18305 (2.3%) | 11965 / 183050 (6.5%) | −146.0 | −144.1 | 0.35 |
| YAP1 SRX10119363 | MCF 10A Breast | 177 / 18305 (1.0%) | 7872 / 183050 (4.3%) | −146.0 | −144.1 | 0.22 |
| CDK9 SRX7366781 | MCF-7 Breast | 239 / 18305 (1.3%) | 146 / 183050 (0.1%) | −145.9 | −144.0 | 16.37 |
| Epitope tags SRX15939724 | RD Muscle | 378 / 18305 (2.1%) | 11336 / 183050 (6.2%) | −145.5 | −143.6 | 0.33 |
| ESR1 SRX2943589 | MCF-7 Breast | 227 / 18305 (1.2%) | 8772 / 183050 (4.8%) | −145.3 | −143.4 | 0.26 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 745 / 18305 (4.1%) | 16844 / 183050 (9.2%) | −145.1 | −143.2 | 0.44 |
| CEBPB SRX150598 | IMR-90 Lung | 886 / 18305 (4.8%) | 18816 / 183050 (10.3%) | −145.0 | −143.1 | 0.47 |
| CHD1 SRX186640 | hESC H1 Pluripotent stem cell | 861 / 18305 (4.7%) | 2874 / 183050 (1.6%) | −144.9 | −143.0 | 3.00 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 299 / 18305 (1.6%) | 10015 / 183050 (5.5%) | −144.9 | −143.0 | 0.30 |
| ESR1 SRX5323873 | MCF-7 Breast | 555 / 18305 (3.0%) | 14055 / 183050 (7.7%) | −144.6 | −142.7 | 0.39 |
| ESR1 SRX2881001 | MCF-7 Breast | 238 / 18305 (1.3%) | 8947 / 183050 (4.9%) | −144.5 | −142.6 | 0.27 |
| ZNF711 SRX7805362 | 293 Kidney | 1492 / 18305 (8.2%) | 6856 / 183050 (3.7%) | −144.5 | −142.6 | 2.18 |
| EP300 SRX1012644 | MCF-7 Breast | 200 / 18305 (1.1%) | 8249 / 183050 (4.5%) | −144.3 | −142.4 | 0.24 |
| RNF2 SRX18954719 | SCC-25 Others | 597 / 18305 (3.3%) | 14661 / 183050 (8.0%) | −144.1 | −142.2 | 0.41 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 889 / 18305 (4.9%) | 3052 / 183050 (1.7%) | −143.8 | −141.9 | 2.91 |
| ESR1 SRX1012633 | MCF-7 Breast | 231 / 18305 (1.3%) | 8795 / 183050 (4.8%) | −143.8 | −141.9 | 0.26 |
| FOXA1 SRX1787652 | MCF-7 Breast | 282 / 18305 (1.5%) | 9687 / 183050 (5.3%) | −143.7 | −141.9 | 0.29 |
| ZEB1 SRX13298925 | MCF-7 Breast | 275 / 18305 (1.5%) | 9563 / 183050 (5.2%) | −143.6 | −141.7 | 0.29 |
| ESR1 SRX1995229 | MCF-7 Breast | 448 / 18305 (2.4%) | 12382 / 183050 (6.8%) | −143.6 | −141.7 | 0.36 |
| CEBPB SRX2194249 | SUM 159PT Breast | 434 / 18305 (2.4%) | 12162 / 183050 (6.6%) | −143.6 | −141.7 | 0.36 |
| MED1 SRX13134690 | 293 Kidney | 1213 / 18305 (6.6%) | 5032 / 183050 (2.7%) | −143.5 | −141.6 | 2.41 |
| NR3C1 SRX10977364 | A549 Lung | 187 / 18305 (1.0%) | 7979 / 183050 (4.4%) | −143.3 | −141.5 | 0.23 |
| MYC SRX150570 | MCF 10A Breast | 289 / 18305 (1.6%) | 9790 / 183050 (5.3%) | −143.2 | −141.3 | 0.30 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 424 / 18305 (2.3%) | 742 / 183050 (0.4%) | −143.2 | −141.3 | 5.71 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 978 / 18305 (5.3%) | 19999 / 183050 (10.9%) | −143.1 | −141.3 | 0.49 |
| FOXA1 SRX1787651 | MCF-7 Breast | 263 / 18305 (1.4%) | 9336 / 183050 (5.1%) | −143.1 | −141.2 | 0.28 |
| SSRP1 SRX3436563 | HT-1080 Bone | 880 / 18305 (4.8%) | 3012 / 183050 (1.6%) | −142.8 | −140.9 | 2.92 |
| EP300 SRX1012643 | MCF-7 Breast | 159 / 18305 (0.9%) | 7422 / 183050 (4.1%) | −142.5 | −140.6 | 0.21 |
| KMT2B DRX059615 | HB1119 Blood | 905 / 18305 (4.9%) | 3166 / 183050 (1.7%) | −142.2 | −140.4 | 2.86 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 534 / 18305 (2.9%) | 1218 / 183050 (0.7%) | −142.1 | −140.2 | 4.38 |
| TAF1 SRX11120885 | MCF-7 Breast | 1728 / 18305 (9.4%) | 8549 / 183050 (4.7%) | −142.1 | −140.2 | 2.02 |
| FOXA1 SRX13814018 | 5637 Others | 280 / 18305 (1.5%) | 9593 / 183050 (5.2%) | −142.0 | −140.1 | 0.29 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 363 / 18305 (2.0%) | 10977 / 183050 (6.0%) | −142.0 | −140.1 | 0.33 |
| ESR1 SRX2513521 | MCF-7 Breast | 211 / 18305 (1.2%) | 8375 / 183050 (4.6%) | −141.7 | −139.9 | 0.25 |
| CEBPB SRX190345 | MCF-7 Breast | 352 / 18305 (1.9%) | 10786 / 183050 (5.9%) | −141.7 | −139.9 | 0.33 |
| NR3C1 SRX18884271 | A549 Lung | 235 / 18305 (1.3%) | 8803 / 183050 (4.8%) | −141.6 | −139.8 | 0.27 |
| ESR1 SRX5323872 | MCF-7 Breast | 453 / 18305 (2.5%) | 12391 / 183050 (6.8%) | −141.6 | −139.7 | 0.37 |
| ARID1A SRX5089388 | MCF-7 Breast | 230 / 18305 (1.3%) | 8709 / 183050 (4.8%) | −141.5 | −139.6 | 0.26 |
| ESR1 SRX2513519 | MCF-7 Breast | 242 / 18305 (1.3%) | 8911 / 183050 (4.9%) | −141.3 | −139.4 | 0.27 |
| FOXA2 SRX100448 | Hep G2 Liver | 511 / 18305 (2.8%) | 13260 / 183050 (7.2%) | −141.2 | −139.3 | 0.39 |
| ESR1 SRX176856 | MCF-7 Breast | 152 / 18305 (0.8%) | 7239 / 183050 (4.0%) | −140.9 | −139.1 | 0.21 |
| MITF SRX7368256 | Hermes 3C Epidermis | 870 / 18305 (4.8%) | 18415 / 183050 (10.1%) | −140.7 | −138.8 | 0.47 |
| RELA SRX2207671 | HUVEC Cardiovascular | 228 / 18305 (1.2%) | 8639 / 183050 (4.7%) | −140.4 | −138.6 | 0.26 |
| NOTCH1 SRX2207669 | HUVEC Cardiovascular | 155 / 18305 (0.8%) | 7267 / 183050 (4.0%) | −139.9 | −138.0 | 0.21 |
| ESR1 SRX1995230 | MCF-7 Breast | 388 / 18305 (2.1%) | 11305 / 183050 (6.2%) | −139.8 | −138.0 | 0.34 |
| FOSL1 SRX17608312 | T24 Others | 170 / 18305 (0.9%) | 7552 / 183050 (4.1%) | −139.8 | −138.0 | 0.23 |
| TFAP2C SRX018833 | MCF-7 Breast | 409 / 18305 (2.2%) | 11633 / 183050 (6.4%) | −139.7 | −137.9 | 0.35 |
| FOXA1 SRX3931054 | MCF-7 Breast | 439 / 18305 (2.4%) | 12102 / 183050 (6.6%) | −139.7 | −137.9 | 0.36 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 187 / 18305 (1.0%) | 7866 / 183050 (4.3%) | −139.6 | −137.8 | 0.24 |
| ESR1 SRX3110723 | MCF-7 Breast | 248 / 18305 (1.4%) | 8962 / 183050 (4.9%) | −139.6 | −137.7 | 0.28 |
| FOXA1 SRX3931043 | MCF-7 Breast | 479 / 18305 (2.6%) | 12716 / 183050 (6.9%) | −139.6 | −137.7 | 0.38 |
| TFAP2C SRX128099 | MCF-7 Breast | 408 / 18305 (2.2%) | 11610 / 183050 (6.3%) | −139.5 | −137.6 | 0.35 |
| SMARCA4 SRX8588625 | Pulmonary artery endothelial cells Cardiovascular | 477 / 18305 (2.6%) | 12669 / 183050 (6.9%) | −139.2 | −137.3 | 0.38 |
| ARID1A SRX5089391 | MCF-7 Breast | 261 / 18305 (1.4%) | 9173 / 183050 (5.0%) | −139.0 | −137.2 | 0.28 |
| HDAC1 SRX20517420 | Keratinocytes Epidermis | 1697 / 18305 (9.3%) | 8406 / 183050 (4.6%) | −139.0 | −137.2 | 2.02 |
| NKX2-1 SRX366170 | NCI-H441 Lung | 348 / 18305 (1.9%) | 10625 / 183050 (5.8%) | −138.9 | −137.1 | 0.33 |
| ESR1 SRX2513518 | MCF-7 Breast | 220 / 18305 (1.2%) | 8439 / 183050 (4.6%) | −138.7 | −136.9 | 0.26 |
| NUTM1 SRX20497472 | 293 Kidney | 743 / 18305 (4.1%) | 2303 / 183050 (1.3%) | −138.7 | −136.8 | 3.23 |
| SSRP1 SRX3436566 | HT-1080 Bone | 316 / 18305 (1.7%) | 381 / 183050 (0.2%) | −138.7 | −136.8 | 8.29 |
| MED1 SRX3946904 | Mesenchymal stem cells Others | 214 / 18305 (1.2%) | 8324 / 183050 (4.5%) | −138.5 | −136.7 | 0.26 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 488 / 18305 (2.7%) | 12812 / 183050 (7.0%) | −138.5 | −136.6 | 0.38 |
| KAT6A DRX366109 | 293 Kidney | 2090 / 18305 (11.4%) | 11285 / 183050 (6.2%) | −138.4 | −136.6 | 1.85 |
| MED1 SRX4937336 | HCT 116 Digestive tract | 1599 / 18305 (8.7%) | 7734 / 183050 (4.2%) | −138.4 | −136.5 | 2.07 |
| RELA SRX7054618 | HAEC Cardiovascular | 448 / 18305 (2.4%) | 12185 / 183050 (6.7%) | −138.1 | −136.2 | 0.37 |
| NR3C1 SRX18884260 | A549 Lung | 262 / 18305 (1.4%) | 9152 / 183050 (5.0%) | −137.8 | −136.0 | 0.29 |
| Epitope tags SRX15939725 | RD Muscle | 350 / 18305 (1.9%) | 10618 / 183050 (5.8%) | −137.8 | −136.0 | 0.33 |
| ZEB1 SRX13298923 | MCF-7 Breast | 190 / 18305 (1.0%) | 7858 / 183050 (4.3%) | −137.6 | −135.8 | 0.24 |
| ESR1 SRX5323877 | MCF-7 Breast | 364 / 18305 (2.0%) | 10830 / 183050 (5.9%) | −137.4 | −135.5 | 0.34 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 296 / 18305 (1.6%) | 9712 / 183050 (5.3%) | −137.3 | −135.4 | 0.30 |
| NR3C1 SRX2609667 | HASM2 Lung | 458 / 18305 (2.5%) | 12301 / 183050 (6.7%) | −137.1 | −135.2 | 0.37 |
| ESR1 SRX1012630 | MCF-7 Breast | 180 / 18305 (1.0%) | 7654 / 183050 (4.2%) | −137.0 | −135.2 | 0.24 |
| HDAC1 SRX17989500 | PBMC Blood | 1598 / 18305 (8.7%) | 7759 / 183050 (4.2%) | −137.0 | −135.2 | 2.06 |
| NR3C1 SRX10976922 | A549 Lung | 189 / 18305 (1.0%) | 7821 / 183050 (4.3%) | −136.9 | −135.1 | 0.24 |
| NR3C1 SRX19024866 | MCF-7 Breast | 162 / 18305 (0.9%) | 7311 / 183050 (4.0%) | −136.9 | −135.1 | 0.22 |
| YAP1 SRX3511910 | Dermal fibroblast Epidermis | 141 / 18305 (0.8%) | 6904 / 183050 (3.8%) | −136.9 | −135.1 | 0.20 |
| RBFOX2 SRX3322781 | K-562 Blood | 2019 / 18305 (11.0%) | 10803 / 183050 (5.9%) | −136.8 | −135.0 | 1.87 |
| MEN1 SRX14030481 | MV-4-11 Blood | 907 / 18305 (5.0%) | 3257 / 183050 (1.8%) | −136.8 | −135.0 | 2.78 |
| FOXL2 SRX6957431 | KGN Gonad | 1037 / 18305 (5.7%) | 20513 / 183050 (11.2%) | −136.8 | −134.9 | 0.51 |
| ESR1 SRX5534832 | MCF-7 Breast | 427 / 18305 (2.3%) | 11806 / 183050 (6.4%) | −136.7 | −134.9 | 0.36 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 800 / 18305 (4.4%) | 17274 / 183050 (9.4%) | −136.7 | −134.8 | 0.46 |
| SUPT6H SRX15147167 | DLD-1 Digestive tract | 1334 / 18305 (7.3%) | 5959 / 183050 (3.3%) | −136.6 | −134.8 | 2.24 |
| FOXA1 SRX5203294 | MCF-7 Breast | 133 / 18305 (0.7%) | 6737 / 183050 (3.7%) | −136.6 | −134.8 | 0.20 |
| TLE3 SRX4815193 | SUM 149PT Breast | 458 / 18305 (2.5%) | 12281 / 183050 (6.7%) | −136.6 | −134.7 | 0.37 |
Showing first 500 of 22446 rows.